HCV Therapy | Room 716
Chairs: Mark Sulkowski & Antonio Craxi
Invited Presentations:
10:30am
Debate: Acute HCV – to treat or wait?
Ira Jacobson, NYU Langone Health, New York & Susanna Naggie, Duke University, Durham
10:55am
When and how to treat decompensated patients with HCV
Xavier Forns, Liver Unit Hospital Clinic Barcelona, Barcelona
11:20am
Treating HCV outside of the liver: management of extrahepatic manifestations
Francesco Negro, University Hospitals Of Geneva, Geneva
Oral Abstracts:
11:45am
Directly Acting Antiviral HCV Therapy is Safe and Effective in Patients with Advanced Cirrhosis: Real World Experience from the HCV-TARGET Cohort
Raj Reddy, University Of Florida, Gainesville
12:00pm
Analysis of AST to Platelet Ratio Index (APRI) for Determining Eligibility for 8 Weeks of Glecaprevir/ Pibrentasvir
Tarik Asselah, Abbvie, Inc., North Chicago